Good afternoon :)
Place Order
Add to Watchlist

Anuh Pharma Ltd

ANUHPHR Share Price

208.802.68% (-5.76)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹1,075 cr, stock is ranked 1,439

High Risk

Stock is 3.05x as volatile as Nifty

ANUHPHR Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹1,075 cr, stock is ranked 1,439

High Risk

Stock is 3.05x as volatile as Nifty

ANUHPHR Performance & Key Metrics

ANUHPHR Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
22.703.690.70%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.776.430.79%

ANUHPHR Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ANUHPHR Company Profile

Anuh Pharma Limited is engaged in the manufacturing of pharmaceuticals, medicinal, chemical and botanical products. The Company manufactures active pharmaceutical ingredients (APIs). It also sells bulk drugs and chemicals.

Investor Presentation

View older View older 

May 29, 2025

PDF
View Older Presentations

ANUHPHR Similar Stocks (Peers)

Compare with peers Compare with peers 

ANUHPHR Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.65
36.65
1Y Return
5.30%
5.30%
Buy Reco %
87.50
87.50
Cipla Ltd
CIPLA
PE Ratio
22.85
22.85
1Y Return
1.35%
1.35%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
59.39
59.39
1Y Return
14.22%
14.22%
Buy Reco %
70.83
70.83
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.68
18.68
1Y Return
3.58%
3.58%
Buy Reco %
51.72
51.72
Mankind Pharma Ltd
MANKIND
PE Ratio
52.37
52.37
1Y Return
20.17%
20.17%
Buy Reco %
81.25
81.25
Compare with Peers

ANUHPHR Forecast

ANUHPHR Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ANUHPHR

ANUHPHR

Income

Balance Sheet

Cash Flow

ANUHPHR Income Statement

ANUHPHR Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 16.61%, vs industry avg of 10.1%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.12% to 0.16%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 27.03%, vs industry avg of 20.04%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue213.73245.47325.36311.17442.50491.85533.60659.10670.97670.97
Raw Materialssubtract148.76184.07249.16243.67327.49382.54388.00501.90600.61600.60
Power & Fuel Costsubtract3.074.094.796.318.668.8011.0212.37
Employee Costsubtract7.228.9010.1413.3614.2915.1017.1519.39
Selling & Administrative Expensessubtract7.458.539.988.9011.1712.0713.2815.50
Operating & Other expensessubtract16.9614.1816.6311.4825.2320.6746.2322.09
Depreciation/Amortizationsubtract1.971.831.667.0315.0811.969.708.588.748.74
Interest & Other Itemssubtract0.720.450.601.262.031.580.750.960.620.61
Taxes & Other Itemssubtract7.546.909.044.8510.128.5611.2918.2513.6613.66
EPS4.003.304.662.865.676.107.2211.999.459.45
DPS1.251.381.381.381.501.752.002.501.502.50
Payout ratio0.310.420.290.480.260.290.280.210.160.26
See Costs

ANUHPHR Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 29PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Jun 3PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Nov 12PDF
Nov 12PDF
Aug 9PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

May 25PDF
Feb 11PDF
Feb 11PDF
+2 more
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

ANUHPHR Stock Peers

ANUHPHR Past Performance & Peer Comparison

ANUHPHR Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Anuh Pharma Ltd22.713.690.70%
Sun Pharmaceutical Industries Ltd36.655.530.96%
Cipla Ltd22.853.851.07%
Torrent Pharmaceuticals Ltd59.3914.950.18%

ANUHPHR Stock Price Comparison

Compare ANUHPHR with any stock or ETF
Compare ANUHPHR with any stock or ETF
ANUHPHR
Loading...

ANUHPHR Holdings

ANUHPHR Shareholdings

ANUHPHR Promoter Holdings Trend

ANUHPHR Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ANUHPHR Institutional Holdings Trend

ANUHPHR Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ANUHPHR Shareholding Pattern

ANUHPHR Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.92%0.00%0.00%0.04%30.05%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ANUHPHR Shareholding History

ANUHPHR Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.03%0.03%0.02%0.02%0.04%

ANUHPHR Insider Trades & Bulk Stock Deals

ANUHPHR Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ANUHPHR stock

smallcases containing ANUHPHR stock

Looks like this stock is not in any smallcase yet.

ANUHPHR Events

ANUHPHR Events

ANUHPHR Dividend Trend

No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ANUHPHR has shown inconsistent dividend trend over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.70%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.99 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ANUHPHR Dividend Trend

No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ANUHPHR has shown inconsistent dividend trend over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.70%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.99 every year

ANUHPHR Upcoming Dividends

ANUHPHR Upcoming Dividends

No upcoming dividends are available

ANUHPHR Past Dividends

ANUHPHR Past Dividends

Cash Dividend

Ex DateEx DateAug 16, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Aug 16, 2024

Cash Dividend

Ex DateEx DateAug 11, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Aug 11, 2023

Cash Dividend

Ex DateEx DateAug 3, 2022

Final
Final | Div/Share: ₹1.75

Dividend/Share

₹1.75

Ex DateEx Date

Aug 3, 2022

Cash Dividend

Ex DateEx DateAug 17, 2021

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Aug 17, 2021

Cash Dividend

Ex DateEx DateMar 5, 2020

Interim
Interim | Div/Share: ₹2.75

Dividend/Share

₹2.75

Ex DateEx Date

Mar 5, 2020

ANUHPHR Stock News & Opinions

ANUHPHR Stock News & Opinions

Corporate
Anuh Pharma fixes record date for bonus issue

Anuh Pharma has fixed 15 July 2025 as record date for issuance of bonus shares in ratio of 1:1. Powered by Capital Market - Live

2 days agoCapital Market - Live
Corporate
Anuh Pharma schedules AGM

Anuh Pharma announced that the 65th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Anuh Pharma recommends final dividend

Anuh Pharma announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Anuh Pharma standalone net profit declines 18.88% in the March 2025 quarter

Net profit of Anuh Pharma declined 18.88% to Rs 12.46 crore in the quarter ended March 2025 as against Rs 15.36 crore during the previous quarter ended March 2024. Sales rose 20.90% to Rs 198.14 crore in the quarter ended March 2025 as against Rs 163.89 crore during the previous quarter ended March 2024. For the full year,net profit declined 21.16% to Rs 47.35 crore in the year ended March 2025 as against Rs 60.06 crore during the previous year ended March 2024. Sales rose 2.24% to Rs 661.51 crore in the year ended March 2025 as against Rs 647.00 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales198.14163.89 21 661.51647.00 2 OPM %9.4311.73 -9.2111.61 - PBDT20.0521.95 -9 69.7586.89 -20 PBT17.2919.72 -12 61.0178.31 -22 NP12.4615.36 -19 47.3560.06 -21 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Anuh Pharma to table results

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Anuh Pharma standalone net profit declines 45.89% in the December 2024 quarter

Net profit of Anuh Pharma declined 45.89% to Rs 10.34 crore in the quarter ended December 2024 as against Rs 19.11 crore during the previous quarter ended December 2023. Sales declined 7.32% to Rs 159.51 crore in the quarter ended December 2024 as against Rs 172.10 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales159.51172.10 -7 OPM %9.2713.93 - PBDT15.4427.50 -44 PBT13.2625.30 -48 NP10.3419.11 -46 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Anuh Pharma schedules board meeting

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Anuh Pharma standalone net profit rises 8.75% in the September 2024 quarter

Net profit of Anuh Pharma rose 8.75% to Rs 15.04 crore in the quarter ended September 2024 as against Rs 13.83 crore during the previous quarter ended September 2023. Sales rose 10.98% to Rs 165.95 crore in the quarter ended September 2024 as against Rs 149.53 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales165.95149.53 11 OPM %10.1712.01 - PBDT20.1120.02 0 PBT18.1917.87 2 NP15.0413.83 9 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Anuh Pharma to conduct board meeting

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Anuh Pharma to announce Quarterly Result

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Anuh Pharma Ltd (ANUHPHR) today?

    The share price of ANUHPHR as on 10th July 2025 is ₹208.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Anuh Pharma Ltd (ANUHPHR) share?

    The past returns of Anuh Pharma Ltd (ANUHPHR) share are
    • Past 1 week: 2.27%
    • Past 1 month: 2.87%
    • Past 3 months: 27.96%
    • Past 6 months: -0.46%
    • Past 1 year: -7.26%
    • Past 3 years: 139.06%
    • Past 5 years: 89.04%

  3. What are the peers or stocks similar to Anuh Pharma Ltd (ANUHPHR)?

    The peers or stocks similar to Anuh Pharma Ltd (ANUHPHR) include:

  4. What is the dividend yield % of Anuh Pharma Ltd (ANUHPHR) share?

    The current dividend yield of Anuh Pharma Ltd (ANUHPHR) is 0.70.

  5. What is the market cap of Anuh Pharma Ltd (ANUHPHR) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Anuh Pharma Ltd (ANUHPHR) is ₹1075.20 Cr as of 10th July 2025.

  6. What is the 52 week high and low of Anuh Pharma Ltd (ANUHPHR) share?

    The 52-week high of Anuh Pharma Ltd (ANUHPHR) is ₹249.95 and the 52-week low is ₹148.50.

  7. What is the PE and PB ratio of Anuh Pharma Ltd (ANUHPHR) stock?

    The P/E (price-to-earnings) ratio of Anuh Pharma Ltd (ANUHPHR) is 22.71. The P/B (price-to-book) ratio is 3.69.

  8. Which sector does Anuh Pharma Ltd (ANUHPHR) belong to?

    Anuh Pharma Ltd (ANUHPHR) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Anuh Pharma Ltd (ANUHPHR) shares?

    You can directly buy Anuh Pharma Ltd (ANUHPHR) shares on Tickertape. Simply sign up, connect your demat account and place your order.